These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8905578

  • 1. Pharmacokinetics of antipyrine in calves after intravenous and oral administration.
    Janus K, Muszczynski Z, Suszycka J.
    J Vet Pharmacol Ther; 1996 Oct; 19(5):408-10. PubMed ID: 8905578
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effect of age and sex on metabolism and urinary excretion of antipyrine.
    Jorquera F, Almar M, Pozuelo M, Sansegundo D, González-Sastre M, González-Gallego J.
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
    [Abstract] [Full Text] [Related]

  • 5. Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine.
    Yang BB, Hounslow NJ, Sedman AJ, Forgue ST.
    J Clin Pharmacol; 1996 Apr; 36(4):356-60. PubMed ID: 8728350
    [Abstract] [Full Text] [Related]

  • 6. The effect of sex on antipyrine metabolism in cattle at different ages.
    Janus K, Antoszek J.
    J Vet Pharmacol Ther; 1999 Jun; 22(3):163-9. PubMed ID: 10447826
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lack of effect of ivermectin on antipyrine and erythromycin disposition in calves.
    Bohlen DM, Burrows GE, Clarke CR, Burrows SL.
    J Vet Pharmacol Ther; 1995 Dec; 18(6):476-8. PubMed ID: 8789704
    [No Abstract] [Full Text] [Related]

  • 11. Effect of experimental fasciolosis on antipyrine metabolism and clearance in water buffaloes.
    Jiang SX, Bayón JE, Ferre I, Mao XZ, González-Gallego J.
    Vet Parasitol; 2000 Mar 01; 88(3-4):177-86. PubMed ID: 10714456
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of tepoxalin and its active metabolite in broiler chickens.
    De Boever S, Neirinckx E, Baert K, De Backer P, Croubels S.
    J Vet Pharmacol Ther; 2009 Feb 01; 32(1):97-100. PubMed ID: 19161461
    [No Abstract] [Full Text] [Related]

  • 15. Phase I clinical study of edaravone in healthy Chinese volunteers: safety and pharmacokinetics of single or multiple intravenous infusions.
    Li H, Xu K, Wang Y, Zhang H, Li T, Meng L, Gong X, Zhang H, Ou N, Ruan J.
    Drugs R D; 2012 Jun 01; 12(2):65-70. PubMed ID: 22762844
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of flunixin in chickens after oral and intravenous administration.
    Musser JM.
    J Vet Pharmacol Ther; 2010 Jun 01; 33(3):312-4. PubMed ID: 20557449
    [No Abstract] [Full Text] [Related]

  • 17. Absence of hepatic enzyme induction in prostate cancer patients receiving 'Casodex' (bicalutamide).
    Kaisary A, Klarskov P, McKillop D.
    Anticancer Drugs; 1996 Jan 01; 7(1):54-9. PubMed ID: 8742099
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.